Search results
14 gru 2023 · Pediatric Patients (2 weeks of age through 12 years of age) Table 1 displays the recommended oral dosage of TAMIFLU for treatment of influenza in pediatric patients 2 weeks of age through 12 years of age and provides information about prescribing the capsule or the formulation for oral suspension.
16 wrz 2024 · Usual Pediatric Dose for Influenza. 2 weeks to less than 1 year: 3 mg/kg orally twice a day. 1 to 12 years: Weight up to 15 kg: 30 mg orally twice a day. Weight 15.1 to 23 kg: 45 mg orally twice a day. Weight 23.1 to 40 kg: 60 mg orally twice a day. Weight at least 40.1 kg: 75 mg orally twice a day.
• Precautions: Creatinine clearance between 10 and 30 ml/min (adjust treatment dose to once daily, prophylaxis dose to alternate day), pregnant and breast-feeding women (Category B1). • Breast feeding: The UK Health Protection Agency has recommended the use of Oseltamivir as
Available as: 12 mg/mL mixture or 75 mg capsules. Treatment dose: . Post-exposure prophylaxis dose: Same doses and volumes as above but once daily for 10 days. Infants < 3 months: prophylaxis not recommended unless the situation is deemed critical due to limited data on use in this age group.
The recommended oral dose of TAMIFLU for prophylaxis of influenza in pediatric patients 1 to 12 years of age based on body weight is shown in Table 1. Prophylaxis in pediatric patients following...
data in infants and children 1 year of age or older and adults showing that a prophylaxis dose equivalent to half the daily treatment dose is clinically efficacious for the prevention of influenza. The following age-adjusted dosing prophylaxis regimen is recommended for infants 0 - 12 months of age (see Section 5.2 for exposur e simulation):
Younger pediatric patients cleared both the prodrug and the active metabolite faster than 132 adult patients resulting in a lower exposure for a given mg/kg dose.
